期刊文献+

CT-MRI与CA125联合检测卵巢癌的诊断价值

下载PDF
导出
摘要 目的探讨CT-MRI与CA125联合检测卵巢癌诊断价值,为临床提高卵巢癌诊断正确率提供可靠依据。方法指定3名具有专业知识及丰富经验的临床医学影像检查人员完成45例卵巢癌患者CT-MRI检查,之后抽取患者静脉血样测量CA125水平,记录患者单纯使用CT及MRI检查诊断结果、单纯使用CA125检查诊断结果及联合使用CT、MRI与CA125检查诊断结果,给予统计学分析后得出结论。结果 CT、MRI检查符合率为75.56%、CA125检查符合率为80.00%,两种检查结果与病理诊断符合率均较低,检查符合率与病理诊断结果符合率对比具有统计学意义(<0.05);经CT、MRI+CA125检查后,患者与病理诊断结果具有较高符合率(91.11%),即联合检查与病理诊断结果差异无统计学意义(>0.05)。结论临床医师应根据患者实际情况,结合多种检查方法,从而准确判断卵巢癌患者病情,使其得到及时有效的临床救治。
出处 《医学信息(医学与计算机应用)》 2014年第18期451-451,共1页 Medical Information
  • 相关文献

参考文献2

二级参考文献21

  • 1Trimbos JB,Parmar M,Vergote I,et aI.ICON 1-ACTION trial,two parallel randomized phase III trial of adjuvant chemotherapy in patient in early stage ovarian cancer.J Natl Cancer Inst,2003,95(2):105-112.
  • 2Bell J,Brady MF,Young RC,et al.Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma:a Gynecologic Oncology Group study.Gynecol Oncol,2006,102(3):432-439.
  • 3Greene MH,Boice JD JR,Greer BE,et al. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. New Engl J Med,1982, 307(23): 1416-1421.
  • 4Aabo K,Adams Adnitt MP,et al.Chemotherapy in advanced ovarian cancer:four systematic meta-analyses of individual patient data from 37 randomized trials.Advanced ovarian cancer trialists' group Brit J.Cancer,1998,78 (11):1479-1487.
  • 5McGuire WP,Ozols RF.Chemotherapy of advanced ovarian cancer. Semin Oncol, 1998,25(3):340-348.
  • 6Muggia FM,Braly PS,Sutton G,et al.Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage II or IV ovarian cancer: a gynecologic oncology group study.J Clin Oncol,2000,18(11):2349.
  • 7DSAlberts,PY Liu,EV Hannigan,et al.Intraperitoneal eisplatin plus intravenous eyclophosphamide versus intravenous eisplatin plus intravenous eyclophosphamide for stage III ovarian cancer.New Engl J Med, 1996,335:1950-1955.
  • 8Armstrong DK,Bundy B,Wenzel Let al.Intraperitoneal cisplatin and paclitaxel in ovarian cancer.New Engl J Med,2006,354:34-43.
  • 9Bookman MA,Brady MF,McGuire WP,et al.Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer:a phase m trial of the gynecologic cancer intergroup.J Clin Oncol, 2009,27(9):1419-1425.
  • 10Orlando M,Costanzo MV,Chacon RD.Randomized trials of combination chemotherapy (combo) versus monotherapy (mono) in relapsed ovarian carcinoma (ROC):a metaanalysis of published data [abstract].J Clin Oncol, 2007,18( 11 ):72.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部